Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CDKN2C anticorps (AA 1-68)

CDKN2C Reactivité: Humain IHC, ELISA, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7148889
  • Antigène Voir toutes CDKN2C Anticorps
    CDKN2C (Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C))
    Épitope
    • 15
    • 13
    • 9
    • 4
    • 2
    • 1
    • 1
    • 1
    AA 1-68
    Reactivité
    • 59
    • 17
    • 11
    • 2
    • 1
    Humain
    Hôte
    • 53
    • 6
    • 1
    Lapin
    Clonalité
    • 53
    • 6
    Polyclonal
    Conjugué
    • 25
    • 5
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CDKN2C est non-conjugé
    Application
    • 47
    • 22
    • 22
    • 13
    • 13
    • 11
    • 5
    • 3
    • 3
    • 1
    Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Cyclin-dependent kinase 4 inhibitor C protein (1-68AA)
    Isotype
    IgG
    Top Product
    Discover our top product CDKN2C Anticorps primaire
  • Indications d'application
    Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    CDKN2C (Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C))
    Autre désignation
    CDKN2C (CDKN2C Produits)
    Synonymes
    anticorps CDKN2C, anticorps p18, anticorps ink4c, anticorps p18-ink4c, anticorps INK4C, anticorps p18-INK4C, anticorps C77269, anticorps INK4c, anticorps INK4d, anticorps p18INK4c, anticorps cyclin dependent kinase inhibitor 2C, anticorps cyclin-dependent kinase inhibitor 2C, anticorps cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4), anticorps CDKN2C, anticorps cdkn2c, anticorps Cdkn2c
    Sujet

    Background: Interacts strongly with CDK6, weakly with CDK4. Inhibits cell growth and proliferation with a correlated dependence on endogenous retinoblastoma protein RB.

    Aliases: CDK6 inhibitor p18 antibody, CDKN 2C antibody, CDKN 6 antibody, Cdkn2c antibody, CDKN6 antibody, CDN2C_HUMAN antibody, Cyclin dependent inhibitor antibody, Cyclin dependent kinase 4 inhibitor C antibody, Cyclin dependent kinase 6 inhibitor antibody, Cyclin dependent kinase 6 inhibitor p18 antibody, Cyclin dependent kinase inhibitor 2C (p18 inhibits CDK4) antibody, Cyclin dependent kinase inhibitor 2C antibody, Cyclin-dependent kinase 4 inhibitor C antibody, Cyclin-dependent kinase 6 inhibitor antibody, INK4C antibody, OTTHUMP00000046546 antibody, p18 antibody, p18 inhibits CDK4 antibody, p18 INK4c antibody, p18 INK6 antibody, p18-INK4c antibody, p18-INK6 antibody

    UniProt
    P42773
    Pathways
    Cycle Cellulaire, Mitotic G1-G1/S Phases
Vous êtes ici: